Development of amphotericin b Based organogels against mucocutaneous fungal infections

Amphotericin B is a broad spectrum antifungal agent used to treat fungal infections. Organogel is a semisolid preparation in which the apolar phase gets immobilized within spaces of the three-dimensional structure. The current study aimed at the formulation and comparative evaluation of sorbitan mon...

Full description

Bibliographic Details
Main Authors: Kavya Gopalan, Jobin Jose
Format: Article
Language:English
Published: Universidade de São Paulo 2020-09-01
Series:Brazilian Journal of Pharmaceutical Sciences
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1984-82502020000100563&tlng=en
_version_ 1811275631105671168
author Kavya Gopalan
Jobin Jose
author_facet Kavya Gopalan
Jobin Jose
author_sort Kavya Gopalan
collection DOAJ
description Amphotericin B is a broad spectrum antifungal agent used to treat fungal infections. Organogel is a semisolid preparation in which the apolar phase gets immobilized within spaces of the three-dimensional structure. The current study aimed at the formulation and comparative evaluation of sorbitan monostearate organogels and pluronic lecithin organogels (PLO). Different compositions of span 60 based organogels were prepared by varying the concentrations of the span 60 and PLO gels were prepared by varying the concentration of Pluronic F 127. The developed organogels were subjected to various characteristics such as pH, viscosity, spreadability, extrudability, and drug release studies. The optimized formulations were evaluated against Candida albicans and carried out ex vivo release study. The optimized formulation was selected from span 60 based organogels, and pluronic lecithin organogels were S1 and P1, respectively. The optimized formulation (S1) showed effective inhibition against Candida albicans. The skin irritation test was carried out on albino mice for optimized formulations and results showed that no irritation to the skin. Based on the results, organogels prepared by sorbitan monostearate showed better antifungal activity, and also all the formulations were found to be stable and safe throughout the study period.
first_indexed 2024-04-12T23:42:16Z
format Article
id doaj.art-2f903673f17146fabe77de9a0b982c00
institution Directory Open Access Journal
issn 2175-9790
language English
last_indexed 2024-04-12T23:42:16Z
publishDate 2020-09-01
publisher Universidade de São Paulo
record_format Article
series Brazilian Journal of Pharmaceutical Sciences
spelling doaj.art-2f903673f17146fabe77de9a0b982c002022-12-22T03:11:57ZengUniversidade de São PauloBrazilian Journal of Pharmaceutical Sciences2175-97902020-09-015610.1590/s2175-97902020000117509Development of amphotericin b Based organogels against mucocutaneous fungal infectionsKavya GopalanJobin Josehttps://orcid.org/0000-0002-2815-5384Amphotericin B is a broad spectrum antifungal agent used to treat fungal infections. Organogel is a semisolid preparation in which the apolar phase gets immobilized within spaces of the three-dimensional structure. The current study aimed at the formulation and comparative evaluation of sorbitan monostearate organogels and pluronic lecithin organogels (PLO). Different compositions of span 60 based organogels were prepared by varying the concentrations of the span 60 and PLO gels were prepared by varying the concentration of Pluronic F 127. The developed organogels were subjected to various characteristics such as pH, viscosity, spreadability, extrudability, and drug release studies. The optimized formulations were evaluated against Candida albicans and carried out ex vivo release study. The optimized formulation was selected from span 60 based organogels, and pluronic lecithin organogels were S1 and P1, respectively. The optimized formulation (S1) showed effective inhibition against Candida albicans. The skin irritation test was carried out on albino mice for optimized formulations and results showed that no irritation to the skin. Based on the results, organogels prepared by sorbitan monostearate showed better antifungal activity, and also all the formulations were found to be stable and safe throughout the study period.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1984-82502020000100563&tlng=enAmphotericin BOrganogelSpan 60Pluronic F127Lecithin
spellingShingle Kavya Gopalan
Jobin Jose
Development of amphotericin b Based organogels against mucocutaneous fungal infections
Brazilian Journal of Pharmaceutical Sciences
Amphotericin B
Organogel
Span 60
Pluronic F127
Lecithin
title Development of amphotericin b Based organogels against mucocutaneous fungal infections
title_full Development of amphotericin b Based organogels against mucocutaneous fungal infections
title_fullStr Development of amphotericin b Based organogels against mucocutaneous fungal infections
title_full_unstemmed Development of amphotericin b Based organogels against mucocutaneous fungal infections
title_short Development of amphotericin b Based organogels against mucocutaneous fungal infections
title_sort development of amphotericin b based organogels against mucocutaneous fungal infections
topic Amphotericin B
Organogel
Span 60
Pluronic F127
Lecithin
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1984-82502020000100563&tlng=en
work_keys_str_mv AT kavyagopalan developmentofamphotericinbbasedorganogelsagainstmucocutaneousfungalinfections
AT jobinjose developmentofamphotericinbbasedorganogelsagainstmucocutaneousfungalinfections